Erythropoiesis‑Stimulating Agents (Epoetin and Darbepoetin) for Treating Anaemia in People with Cancer Having Chemotherapy (TA323) (including review of TA142)

Eltrombopag for Treating Chronic Immune (Idiopathic) Thrombocytopenic Purpura (TA293 [Review of TA205])

Rivaroxaban for Treating Pulmonary Embolism and Preventing Recurrent Venous Thromboembolism (TA287)

Apixaban for Preventing Stroke and Systemic Embolism in People with Nonvalvular Atrial Fibrillation (TA275)

Ivabradine for Treating Chronic Heart Failure (TA267)

Alteplase for Treating Acute Ischaemic Stroke (TA264 [Review of TA122])

Rivaroxaban for the Treatment of Deep Vein Thrombosis and Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism (TA261)

Rivaroxaban for the Prevention of Stroke and Systemic Embolism in People with Atrial Fibrillation (TA256)

Dabigatran Etexilate for the Prevention of Stroke and Systemic Embolism in Atrial Fibrillation (TA249)

Apixaban for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Adults (TA245)

Load More